{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:18:53Z","timestamp":1768677533134,"version":"3.49.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":653,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/IVC-PEC\/1302\/2013"],"award-info":[{"award-number":["EXPL\/IVC-PEC\/1302\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-TOX\/114166\/2009"],"award-info":[{"award-number":["PTDC\/SAU-TOX\/114166\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/112005\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/112005\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.repc.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T18:45:17Z","timestamp":1499107517000},"page":"551-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs"],"prefix":"10.1016","volume":"36","author":[{"given":"Ana Catarina","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Reina-Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Albino-Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2017.05.008_bib0440","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0445","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0000000000000162","article-title":"Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study","volume":"32","author":"Polonia","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0450","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2017.05.008_bib0455","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2017.05.008_bib0460","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2017.05.008_bib0465","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2017.05.008_bib0470","first-page":"17","article-title":"Benefits of low-dose aspirin in patients with hypertension","volume":"19","author":"Beygui","year":"2010","journal-title":"Hot Top Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0475","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2017.05.008_bib0480","first-page":"423","article-title":"Influence of acetylsalicylic acid on acute circulatory effects of the beta-blocking agents pindolol and propranolol in humans","volume":"20","author":"Sziegoleit","year":"1982","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.repc.2017.05.008_bib0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0009-9236(98)90123-0","article-title":"Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction","volume":"63","author":"Guazzi","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.repc.2017.05.008_bib0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(25)23297-9","article-title":"Inhibition by metoprolol of the antihypertensive effect of aspirin in young rats","volume":"234","author":"Tuttle","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.repc.2017.05.008_bib0495","first-page":"S463","article-title":"Influence of indometacin and acetylsalicylic acid on the therapeutic effectiveness of talinolol in patients with essential hypertension","volume":"43","author":"Sziegoleit","year":"1984","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.repc.2017.05.008_bib0500","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0895-7061(00)00231-4","article-title":"Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)\u2013Hypertension study","volume":"13","author":"Avanzini","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0505","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0895-7061(99)00037-0","article-title":"Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan","volume":"12","author":"Nawarskas","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0510","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacc.2005.05.060","article-title":"The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study","volume":"46","author":"Fossum","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0515","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0735-1097(01)01641-2","article-title":"Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers","volume":"38","author":"Lindenfeld","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9149(96)00696-0","article-title":"Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)","volume":"79","author":"Nguyen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0525","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2017.05.008_bib0530","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11906-010-0115-5","article-title":"Antihypertensive effects of aspirin: what is the evidence?","volume":"12","author":"Bautista","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.repc.2017.05.008_bib0535","doi-asserted-by":"crossref","first-page":"173124","DOI":"10.1155\/2012\/173124","article-title":"Aspirin: pharmacology and clinical applications","volume":"2012","author":"Paez Espinosa","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.repc.2017.05.008_bib0540","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","article-title":"Physiological regulation of prostaglandins in the kidney","volume":"70","author":"Hao","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0545","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/HJR.0b013e32833ace3a","article-title":"Low-dose acetylsalicylic acid and blood pressure control in drug-treated hypertensive patients","volume":"18","author":"Leinonen","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.repc.2017.05.008_bib0550","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2007-999562","article-title":"Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia","volume":"6","author":"Walsh","year":"1989","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.repc.2017.05.008_bib0555","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.36.2.276","article-title":"Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake","volume":"36","author":"Rodriguez","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0560","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.repc.2017.05.008_bib0565","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2174\/1389450117666160101121135","article-title":"Resolving inflammation in heart failure: novel protective lipid mediators","volume":"17","author":"Reina-Couto","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.repc.2017.05.008_bib0570","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.repc.2017.05.008_bib0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.repc.2017.05.008_bib0580","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.repc.2017.05.008_bib0585","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/01.CIR.0000140985.89766.CB","article-title":"Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone","volume":"110","author":"von der Weid","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2017.05.008_bib0590","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/eci.12265","article-title":"Impaired resolution of inflammation in human chronic heart failure","volume":"44","author":"Reina-Couto","year":"2014","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.repc.2017.05.008_bib0595","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cmet.2014.09.004","article-title":"The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism","volume":"20","author":"Demetz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.repc.2017.05.008_bib0600","first-page":"6708","article-title":"Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXR\u03b1 signaling pathway in THP-1 macrophage-derived foam cells","volume":"8","author":"Sha","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.repc.2017.05.008_bib0605","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","article-title":"Role of oxidative stress in cardiovascular diseases","volume":"18","author":"Dhalla","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0610","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","volume":"71","author":"Siti","year":"2015","journal-title":"Vasc Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.repc.2017.05.008_bib0615","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.2337\/dc08-s247","article-title":"NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities","volume":"31","author":"Paravicini","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.repc.2017.05.008_bib0620","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejphar.2008.04.044","article-title":"Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors","volume":"588","author":"Sousa","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0625","series-title":"Lipid peroxidation","first-page":"345","article-title":"Lipid peroxidation and antioxidants in arterial hypertension","author":"Sousa","year":"2012"},{"key":"10.1016\/j.repc.2017.05.008_bib0630","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/j.1476-5381.2012.01957.x","article-title":"Role of H2O2 in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II","volume":"166","author":"Sousa","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0635","first-page":"1","article-title":"Causal link between oxidative stress, inflammation, and hypertension","volume":"2","author":"Vaziri","year":"2008","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.repc.2017.05.008_bib0640","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hc0302.102609","article-title":"Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats","volume":"105","author":"Wu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2017.05.008_bib0645","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00004872-200404000-00023","article-title":"Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats","volume":"22","author":"Wu","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0650","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.taap.2012.01.013","article-title":"Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription","volume":"259","author":"Wang","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0655","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH06-06-0315","article-title":"Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism","volume":"97","author":"Nascimento-Silva","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.repc.2017.05.008_bib0660","doi-asserted-by":"crossref","first-page":"C557","DOI":"10.1152\/ajpcell.00045.2005","article-title":"Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells","volume":"289","author":"Nascimento-Silva","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0665","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1096\/fj.12-223982","article-title":"15-Epi-lipoxin A4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1","volume":"27","author":"Carlo","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.repc.2017.05.008_bib0670","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation. NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"Jozsef","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.repc.2017.05.008_bib0675","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cvr\/cvp084","article-title":"Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA\/Rho-kinase activation","volume":"83","author":"Ying","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.repc.2017.05.008_bib0680","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.HYP.37.1.148","article-title":"Salicylate inhibits phosphorylation of the nonreceptor tyrosine kinases, proline-rich tyrosine kinase 2 and c-Src","volume":"37","author":"Wang","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0685","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0898-6568(99)00076-5","article-title":"RAFTK\/Pyk2-mediated cellular signalling","volume":"12","author":"Avraham","year":"2000","journal-title":"Cell Signal"},{"key":"10.1016\/j.repc.2017.05.008_bib0690","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.CIR.97.8.716","article-title":"Aspirin improves endothelial dysfunction in atherosclerosis","volume":"97","author":"Husain","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2017.05.008_bib0695","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0008-6363(98)00013-3","article-title":"Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin","volume":"38","author":"Noon","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.repc.2017.05.008_bib0700","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/clc.4960241104","article-title":"Effects of low-dose aspirin on endothelial function in hypertensive patients","volume":"24","author":"Monobe","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0705","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0710","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1440-1681.1983.tb00212.x","article-title":"Differences in arachidonic acid metabolism and effects of aspirin between one- and two-kidney Goldblatt hypertensive rats","volume":"10","author":"Dusting","year":"1983","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0715","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1476-5381.1988.tb11585.x","article-title":"Age and the antihypertensive effect of aspirin in rats","volume":"94","author":"Tuttle","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0720","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1476-5381.1993.tb13704.x","article-title":"Different effects of aspirin on blood pressure of spontaneously hypertensive rats (SHR) with high and spontaneously low levels of blood pressure","volume":"109","author":"Schirner","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0725","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00004872-200207000-00028","article-title":"Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats","volume":"20","author":"El Midaoui","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0730","first-page":"37","article-title":"Effect of aspirin on the contractility of aortic smooth muscle and the course of blood pressure development in male spontaneously hypertensive rats","volume":"23","author":"Rahmani","year":"1998","journal-title":"Artery"},{"key":"10.1016\/j.repc.2017.05.008_bib0735","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.2741\/A365","article-title":"Vascular smooth muscle, endothelial regulation and effects of aspirin in hypertension","volume":"3","author":"Rahmani","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.repc.2017.05.008_bib0740","doi-asserted-by":"crossref","first-page":"F1072","DOI":"10.1152\/ajprenal.00430.2004","article-title":"Effect of COX inhibitors and NO on renal hemodynamics following ischemia-reperfusion injury in normotensive and hypertensive rats","volume":"289","author":"Knight","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0745","article-title":"Interaction of low-dose acetylsalicylic acid with losartan: effect on systolic blood pressure, renal function, oxidative stress and lipoxins synthesis in spontaneous hypertension [abstract]","volume":"31","author":"Sousa","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0750","first-page":"250","article-title":"Parecoxib increases blood pressure through inhibition of cyclooxygenase-2 messenger RNA in an experimental model","volume":"67","author":"Vertiz-Hernandez","year":"2015","journal-title":"Rev Investig Clin"},{"key":"10.1016\/j.repc.2017.05.008_bib0755","first-page":"4","article-title":"Low-dose aspirin improves renal function and antihypertensive efficacy in hypertensive rats treated with losartan [abstract]","volume":"4","author":"Sousa","year":"2014","journal-title":"J Nephrol Ther"},{"key":"10.1016\/j.repc.2017.05.008_bib0760","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1681.1981.tb00738.x","article-title":"Failure of aspirin to modify the hypotensive action of captopril in spontaneously hypertensive rats","volume":"8","author":"DiNicolantonio","year":"1981","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0765","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.HYP.10.3.294","article-title":"Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats","volume":"10","author":"Quilley","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0770","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/0960327103ht331oa","article-title":"Potential adverse interaction between aspirin and lisinopril in hypertensive rats","volume":"22","author":"Dubey","year":"2003","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.repc.2017.05.008_bib0775","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2125.1996.00480.x","article-title":"Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid","volume":"42","author":"Boger","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.repc.2017.05.008_bib0780","first-page":"201","article-title":"Time-dependent effects of ASA administration on blood pressure in healthy subjects","volume":"21","author":"Hermida","year":"1994","journal-title":"Chronobiologia"},{"key":"10.1016\/j.repc.2017.05.008_bib0785","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/07420529709001452","article-title":"Influence of aspirin usage on blood pressure: dose and administration-time dependencies","volume":"14","author":"Hermida","year":"1997","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.repc.2017.05.008_bib0790","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.HYP.0000072335.73748.0D","article-title":"Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients","volume":"41","author":"Hermida","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0795","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jacc.2004.08.071","article-title":"Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients","volume":"46","author":"Hermida","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0800","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/01.HYP.0000172623.36098.4e","article-title":"Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives","volume":"46","author":"Hermida","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0805","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/07420521003624662","article-title":"Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects","volume":"27","author":"Ayala","year":"2010","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.repc.2017.05.008_bib0810","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/08037059409102263","article-title":"Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients","volume":"3","author":"Magagna","year":"1994","journal-title":"Blood Press"},{"key":"10.1016\/j.repc.2017.05.008_bib0815","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.109.134825","article-title":"Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines","volume":"54","author":"Snoep","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0820","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.30.3.589","article-title":"Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women","volume":"30","author":"Hermida","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0825","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.HYP.34.4.1016","article-title":"Administration time-dependent effects of aspirin in women at differing risk for preeclampsia","volume":"34","author":"Hermida","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0830","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.HYP.0000047876.63997.EE","article-title":"Administration time-dependent influence of aspirin on blood pressure in pregnant women","volume":"41","author":"Hermida","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.repc.2017.05.008_bib0835","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ajh.2009.83","article-title":"Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension","volume":"22","author":"Hermida","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0840","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1681\/ASN.V451133","article-title":"Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril","volume":"4","author":"Smith","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.repc.2017.05.008_bib0845","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00004872-199508000-00014","article-title":"Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients","volume":"13","author":"Polonia","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0850","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.jhh.1001406","article-title":"Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors","volume":"16","author":"Fisman","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0855","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1081\/CEH-48733","article-title":"Chronobiologically explored effects of Telmisartan","volume":"27","author":"Prikryl","year":"2005","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0860","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/00004872-200211000-00031","article-title":"Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2017.05.008_bib0865","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1741826711418165","article-title":"Is there a BP benefit of changing the time of aspirin administration in treated hypertensive patients?","volume":"19","author":"Dimitrov","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repc.2017.05.008_bib0870","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/HYPERTENSIONAHA.114.04980","article-title":"Time-dependent effects of aspirin on blood pressure and morning platelet reactivity: a randomized crossover trial","volume":"65","author":"Bonten","year":"2015","journal-title":"Hypertension"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117302895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117302895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:05:14Z","timestamp":1760108714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255117302895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":87,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0870255117302895"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2017.05.008","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}